Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

MRD Detection in Standard-Risk Pediatric AML Using Single-Cell RNA Sequencing

Rula Gladden, Everett Fan, Shruti Bhise, Rhonda E. Ries, Rachel Ferina, Sami B. Kanaan, Mark A Mendoza, Jobelle Peralta, Rachel Gate, Soheil Meshinchi, Scott N Furlan

Blood (2024) 144 (Supplement 1): 1571.

https://doi.org/10.1182/blood-2024-211589

Published: 2024

Journal Articles

Contrasting Clinical Implications of NRAS Vs. KRAS Mutations in AML - Only KRAS Mutations Are Associated with Adverse Outcome

John N Colgan, Jack H. Peplinski, Danielle C. Kirkey, Adam Lamble, Rhonda E. Ries, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 1555.

https://doi.org/10.1182/blood-2024-202833

Published: 2024

Journal Articles

Comprehensive Characterization of Rare Recurrent Mutations in Pediatric AML

Adam Lamble, Rhonda E. Ries, Jack H. Peplinski, Logan K. Wallace, Danielle C. Kirkey, Xiaotu Ma, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 849.

https://doi.org/10.1182/blood-2024-208864

Published: 2024

Journal Articles

Identification of DLK1 As a Novel Therapeutic Target in Down Syndrome Myeloid Leukemia

Sonali P Barwe, Meredith Tavenner, Patrick Van Berkel, Aimy Sebastian, Rhonda E. Ries, Soheil Meshinchi, Johann K. Hitzler, Yana Pikman, Anders Kolb, Anilkumar Gopalakrishnapillai

Blood (2024) 144 (Supplement 1): 209.

https://doi.org/10.1182/blood-2024-211364

Published: 2024

Journal Articles

Haplo-Insufficiency of RAS Genes Is the Determinant of Outcome in AML

Jack H. Peplinski, Logan K. Wallace, Rhonda E. Ries, Xiaotu Ma, Danielle C. Kirkey, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 1562.

https://doi.org/10.1182/blood-2024-208953

Published: 2024

Journal Articles

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Francisco Marchi, Ann-Kathrin Schade, Vivek M. Shastri, Xueyuan Cao, Raul C. Ribeiro, Jeffrey E. Rubnitz, Jeffery M Klco, Alan S Gamis, Rhonda E. Ries, Anders Kolb, Richard Aplenc, Todd A. Alonzo, Stanley Pounds, Soheil Meshinchi, Jatinder K. Lamba

Blood (2024) 144 (Supplement 1): 103.

https://doi.org/10.1182/blood-2024-207665

Published: 2024

Journal Articles

Age-Stratified Game-Theory-Informed Machine Learning of Molecular Alterations Unveils Prognostic Divergence in 3062 Pediatric and Adult Acute Myeloid Leukemia Patients

Blood (2024) 144 (Supplement 1): 2211.

https://doi.org/10.1182/blood-2024-198861

Published: 2024

Journal Articles

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

Lauren Harmon, Zachary S Hattig, Yizhou Peter Huang, Caliese Beckford, Xiaotu Ma, Rhonda E. Ries, Soheil Meshinchi, Lucy Godley, Timothy J Triche, Jr.

Blood (2024) 144 (Supplement 1): 4092.

https://doi.org/10.1182/blood-2024-210515

Published: 2024

Journal Articles

The AML HOX-Ome: The Landscape of Developmental Transcription Factors across Pediatric Acute Myeloid Leukemia

Logan K. Wallace, Jack H. Peplinski, Rhonda E. Ries, Danielle C. Kirkey, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 2925.

https://doi.org/10.1182/blood-2024-211754

Published: 2024

Journal Articles

Dysregulation of Developmental Transcription Factors in Acute Myeloid Leukemia Predicts Poor Outcome and Impacts Adaptive Immune Pathway Genes

Logan K. Wallace, Jack H. Peplinski, Rhonda E. Ries, Danielle C. Kirkey, Xiaotu Ma, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 638.

https://doi.org/10.1182/blood-2024-194524

Published: 2024

Journal Articles

Potent Target-Specific Efficacy of CAR T Cells Directed Toward the AML and KMT2A-Rearranged Specific Antigen CLEC2A

Danielle C. Kirkey, Grace Hawkins, Melia Blankenfeld, Isabel Lira, Nika Panahi, Margaret G Hines, Seungmin Shin, Tiffany Hylkema, Cyd McKay, Christina Root, Logan K. Wallace, Jack H. Peplinski, Rhonda E. Ries, Concetta Quintarelli, Franco Locatelli, Wei Li, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 2050.

https://doi.org/10.1182/blood-2024-212075

Published: 2024

Journal Articles

Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG

Vivian M. Liu, Megan Othus, Rhonda E. Ries, Jasmine Naru, Era L. Pogosova-Agadjanyan, Frederick R. Appelbaum, Lan W. Beppu, Thomas R. Chauncey, Harry P. Erba, John E. Godwin, Matthew Fitzgibbon, Min Fang, Stanley C. Lee, Anna B. Moseley, Jerald P. Radich, Cheryl L. Willman, Feinan Wu, Soheil Meshinchi, Derek L. Stirewalt

Blood (2024) 144 (Supplement 1): 4309.

https://doi.org/10.1182/blood-2024-198506

Published: 2024

Journal Articles

Discovery and Immunotherapeutic Targeting of the Tumor-Specific Target LAMP5 in Acute Myeloid Leukemia

Grace Hawkins, Danielle Kirkey, Nika Panahi, Melia Blankenfeld, Isabel Lira, Tiffany Hylkema, Cyd McKay, Christina Root, Jack H. Peplinski, Logan K. Wallace, Rhonda E. Ries, Laura Pardo, Michael R. Loken, Soheil Meshinchi

Blood (2024) 144 (Supplement 1): 3413.

https://doi.org/10.1182/blood-2024-204043

Published: 2024

Journal Articles

Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Benjamin J Huang, Lauren K. Meyer, Adam Lamble, Jim Wang, Rhonda E Ries, Alan S Gamis, Richard Aplenc, Katherine Tarlock, Todd Cooper, E. Anders Kolb, Todd A. Alonzo, Soheil Meshinchi, Joseph Chewning, William G. Woods, John T. Horan

Blood (2023) 142 (Supplement 1): 655.

https://doi.org/10.1182/blood-2023-186955

Published: 2023

Journal Articles

A Longitudinal Single-Cell Atlas of Treatment Response in Pediatric AML

Sander Lambo, Diane L. Trinh, Rhonda E Ries, Dan Jin, Audi Setiadi, Michelle Ng, Veronique G. Leblanc, Suzanne Vercauteren, Soheil Meshinchi, Marco Marra

Blood (2023) 142 (Supplement 1): 65.

https://doi.org/10.1182/blood-2023-187408

Published: 2023

Journal Articles

Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers

Nathaniel J Buteyn, Connor Burke, Eve Gardner, Vincent J Sartori, Rhonda E Ries, Todd A. Alonzo, Soheil Meshinchi, Timothy Triche, Jr.

Blood (2023) 142 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2023-189474

Published: 2023

Journal Articles

LAMP5 Is an AML-Restricted Immunotherapeutic Target Enriched in High-Risk Acute Myeloid Leukemia

Nika Panahi, Tiffany Hylkema, Grace Hawkins, Makia K Manselle, Jack H Peplinski, Logan K Wallace, Rhonda E Ries, Soheil Meshinchi, Danielle C Kirkey

Blood (2023) 142 (Supplement 1): 1585.

https://doi.org/10.1182/blood-2023-188352

Published: 2023

Journal Articles

Potent and Target Specific Cytotoxicity of PRAME TCR Mimic CAR T Cells in KMT2A-Rearranged AML Patient-Derived Xenograft Model

Danielle C Kirkey, Leila Robinson, Tiffany Hylkema, Anisha Loeb, Rhonda E Ries, Cyd McKay, Christina Root, Laura Pardo, Keith R. Loeb, Quy Le, David A. Scheinberg, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4821.

https://doi.org/10.1182/blood-2023-188391

Published: 2023

Journal Articles

Identification of a Relapse Signature in t(8;21) Pediatric AML

Logan K Wallace, Jack H Peplinski, Rhonda E Ries, Benjamin J Huang, Xiaotu Ma, Scott N Furlan, Danielle C Kirkey, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4318.

https://doi.org/10.1182/blood-2023-189817

Published: 2023

Journal Articles

DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML

Rhonda E Ries, Xiaotu Ma, Claudia Tregnago, Todd A. Alonzo, Jim Wang, Tiffany Hylkema, Benjamin J Huang, Alireza Torabi, Jack H Peplinski, Logan K Wallace, Richard Aplenc, Alan S Gamis, Katherine Tarlock, Franco Locatelli, Martina Pigazzi, Soheil Meshinchi

Blood (2023) 142 (Supplement 1): 4306.

https://doi.org/10.1182/blood-2023-181060

Published: 2023

NARROW

MRD Detection in Standard-Risk Pediatric AML Using Single-Cell RNA Sequencing

Contrasting Clinical Implications of NRAS Vs. KRAS Mutations in AML - Only KRAS Mutations Are Associated with Adverse Outcome

Comprehensive Characterization of Rare Recurrent Mutations in Pediatric AML

Identification of DLK1 As a Novel Therapeutic Target in Down Syndrome Myeloid Leukemia

Haplo-Insufficiency of RAS Genes Is the Determinant of Outcome in AML

Rapid Long-Read Epigenomic Diagnosis and Prognosis of Acute Myeloid Leukemia

Age-Stratified Game-Theory-Informed Machine Learning of Molecular Alterations Unveils Prognostic Divergence in 3062 Pediatric and Adult Acute Myeloid Leukemia Patients

Germline Variant Burden Warrants Universal Genetic Testing in Pediatric AML

The AML HOX-Ome: The Landscape of Developmental Transcription Factors across Pediatric Acute Myeloid Leukemia

Dysregulation of Developmental Transcription Factors in Acute Myeloid Leukemia Predicts Poor Outcome and Impacts Adaptive Immune Pathway Genes

Potent Target-Specific Efficacy of CAR T Cells Directed Toward the AML and KMT2A-Rearranged Specific Antigen CLEC2A

Evaluation of ELN2022 Risk Stratification in NPM1 Mutated AML: A Study from the Fred Hutch and SWOG

Discovery and Immunotherapeutic Targeting of the Tumor-Specific Target LAMP5 in Acute Myeloid Leukemia

Impact of Molecular Risk on Efficacy of Blood and Marrow Transplantation for Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

A Longitudinal Single-Cell Atlas of Treatment Response in Pediatric AML

Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers

LAMP5 Is an AML-Restricted Immunotherapeutic Target Enriched in High-Risk Acute Myeloid Leukemia

Potent and Target Specific Cytotoxicity of PRAME TCR Mimic CAR T Cells in KMT2A-Rearranged AML Patient-Derived Xenograft Model

Identification of a Relapse Signature in t(8;21) Pediatric AML

DNMT3A Mutants Are Enriched in NPMc+ AML and Associated with Adverse Outcome in Childhood AML

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only